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New Findings 
What is the central question of this study?  
An interaction exists between the regulatory systems of respiration and cerebral blood 
flow (CBF), because of the same mediator (carbon dioxide, CO2) for both physiological 
systems. The present study examined whether the traditional method for determining 
cerebrovascular reactivity to CO2 (cerebrovascular reactivity; CVR) is modified by 
changes in respiration. 
What is the main finding and its importance? 
CVR was modified by voluntary changes in respiration during hypercapnia. This finding 
suggests that an alteration in the respiratory system may under- or over-estimate CVR 
determined by traditional methods in healthy adults. 
 
ABSTRACT 
The cerebral vasculature is sensitive to changes in the arterial partial pressure of carbon 
dioxide (CO2). This physiological mechanism has been well established as a 
cerebrovascular reactivity to CO2 (CVR). However, arterial CO2 may not be an 
independent variable in the traditional method to assess CVR since the cerebral blood 
flow (CBF) response is partly affected by the activation of respiratory drive or higher 
centers in the brain. We hypothesized that CVR is modified by changes in respiration. To 
test our hypothesis, in the present study, ten young healthy subjects performed hyper- or 
hypo-ventilation to change end-tidal CO2 (PETCO2) under different concentrations of CO2 
gas inhalation (0, 2.0, 3.5%). We measured middle cerebral artery mean blood flow 
velocity (MCAVm) by transcranial Doppler to identify the CBF response to change in 
PETCO2 during each condition. At each FICO2 condition, PETCO2 was significantly altered 
by changes in ventilation, and MCA Vm changed accordingly. However, the relationship 
between changes in MCV Vm and PETCO2 as a response curve of CVR was reset upwards 
and downwards by hypo- and hyper-ventilation, respectively, compared with CVR during 
normal-ventilation. The findings of the present study may provide the possibility that an 
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alteration in respiration under- or over-estimates CVR determined by the traditional 
methods. 
 
Key words: respiratory, ventilation, central respiratory chemoreflex, higher center drive, 





The cerebral vasculature is sensitive to changes in the arterial partial pressure of carbon 
dioxide (CO2) (Kety & Schmidt, 1946, 1948a, b; Markwalder et al., 1984). This 
physiological response of the cerebral vasculature is termed “cerebrovascular reactivity 
to CO2 (CVR).” For example, patients with cerebral vascular disease often present with 
an attenuated CVR (Markus & Cullinane, 2001; Glodzik et al., 2013; Richiardi et al., 
2015), indicating that the CVR plays an important role in cerebral blood flow (CBF) 
regulation. In investigations regarding the cerebral circulation, therefore, many 
researchers have measured CVR as one of the key CBF regulatory mechanisms.  
The method of determining CVR has been well established, and the CVR is 
identified by the response of CBF to the change in arterial partial pressure of CO2, which 
is manipulated by changes in end-tidal CO2 in inspiratory gas (hypercapnia) and 
hyper-ventilation (hypocapnia)(Markwalder et al., 1984). Importantly, this methodology 
is based on the basic concept that CBF responds primarily to changes in CO2 with little 
influence of other physiological factors. However, it has been suggested that several 
other physiological factors in combination with arterial CO2 concentration, such as 
respiration, also contributes to a change in CBF at rest (Ogoh & Ainslie, 2009a, b). 
Respiratory disease such as sleep apnea, or acute and chronic hypoxia alters 
CBF regulation (Ogoh et al., 2013; Ogoh et al., 2014; Ponsaing et al., 2018), suggesting 
that alteration in the function of the respiratory system modifies the cerebral circulation. 
Indeed, our previous findings (Ogoh et al., 2008; Ogoh et al., 2009) demonstrated that an 
interaction exists between the regulatory systems of respiration and CBF, because the 
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same mediator (CO2) regulates both the central respiratory chemoreflex and CVR. For 
example, in the traditional method to determine CVR with hypercapnia, the operating 
point of arterial CO2 tension (PETCO2) should be due to the balance between respiratory 
gas CO2 concentration and any increase in ventilation (respiratory drive) via activation of 
the central respiratory chemoreflex. Also, by using hypocapnia, voluntary 
hyperventilation is caused by the activation of higher centers in the brain (central neural 
drive, which is additive to the chemoreflex drive to breathe) that may affect both cerebral 
vasculature and the respiratory system via increases in sympathetic nervous activity. 
Therefore, the traditional method for determining CVR via changes in CO2 modifies the 
respiratory system, which may indirectly affect the CBF response to changes in CO2. 
Therefore, under hypercapnia or hypocapnia conditions, it is possible that PaCO2 may 
not be an independent variable to determine traditional CVR, as the CBF response is 
affected partly by activation of respiratory drive or higher centers in the brain. However, 
no study investigated the effect of respiration on CVR determination regarding the 
traditionally used methods of hyper- and hypocapnia. Under these backgrounds, we 
hypothesized that CVR is modified by changes in respiration. To test our hypothesis, in 
the present study, we measured the CVR response to changes in ventilation (hyper- or 
hypo-ventilation) under stepwise steady-state CO2 gas concentrations. 
Methods 
Ethical approval 
The present study was approved by the Human Subjects Committee of Morinomiya 
University of Medical Sciences (No. 2018-057). All procedures in the present study 
conformed to the standards set by the Declaration of Helsinki. This study was not 
registered in a database. Each subject provided written informed consent to participate 
in the present study. 
Participants  
Ten healthy subjects (Nine men and one female; aged 20.9 ± 1.0 years, height 169.2 ± 5.9 
cm, weight 64.5 ± 8.3 kg, mean ± SD) were recruited to participate in the study. All 
subjects were free of any known cardiovascular and pulmonary disorders, and were not 
using prescribed or over the counter medications. Before the experiment, each subject 
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visited the laboratory for familiarization with the techniques and procedures. When 
visiting the laboratory, subjects were requested to abstain from caffeinated beverages for 
12 h and strenuous physical activity and alcohol for at least 24 h before the day of the 
experiment. 
Measurements 
All studies were performed at a constant room temperature between 23 and 24°C with 
external stimuli minimized. Heart rate (HR) was monitored using a lead II 
electrocardiogram (ECG), and measured using a cardiotachometer (AT601G, Nihon 
Kohden, Tokyo, Japan) triggered by the R wave on the electrocardiogram. Blood pressure 
was measured at 1-min intervals with an automatic manometer placed over the left 
radial artery (EBP-300, Minato Medical Science Co., LTD, Osaka, JAPAN) at 1-min 
intervals. The middle cerebral artery blood velocity (MCA V) was obtained continuously 
by transcranial Doppler ultrasonography (DWL Doppler Box-X; Compumedics, 
Germany). A 2 MHz Doppler probe was placed over the right temporal window and fixed 
with an adjustable headband and adhesive ultrasonic gel. Ventilatory responses were 
measured using an open-circuit apparatus (model 8250, Hans Rudolf). The subject 
breathed through a face mask attached to a low-resistance one-way valve with a flow 
meter (ARCO2000-MET, Arcosystem, Chiba, Japan). The valve mechanism allowed 
subjects to inspire room air or a selected gas mixture from a 200 l Douglas bag containing 
0.0, 2.0 or 3.5% CO2 in 21% O2 with nitrogen (N2) balance. The total instrumental dead 
space was 200 ml. Respiratory and metabolic data during the experiments were recorded 
by an automatic breath-by-breath respiratory gas-analyzing system consisting of a 
differential pressure transducer, sampling tube, filter, suction pump and mass 
spectrometer (ARCO2000-MET, Arco System, Chiba, Japan). Oxygen and CO2 
measurements were calibrated using a standard gas of known concentrations before each 
test. We digitized expired flow, CO2 and O2 concentrations, and derived tidal volume (VT), 
minute ventilation (VE), end-tidal O2 (PETO2) and end-tidal CO2 (PETCO2). Flow signals 
were converted to single breath data by matching to gas concentrations identified as 
single breaths using PETCO2, after accounting for the time lag (350 ms) in gas 
concentration measurements. The corresponding O2 uptake and CO2 output values for 
each breath were calculated from inspired-expired gas concentration differences, and by 
expired ventilation (VE), with inspired ventilation being calculated by N2 correction. 
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Experimental protocol 
Before the experiment day, each subject underwent the same experiment procedures as 
those used during the main experimental day to ensure familiarization with the 
experimental protocols. On the experimental day, subjects arrived at the laboratory at 
least 2 h after a light meal. The present study consisted of two protocols (Protocol 1 and 
2, Fig. 1). 
PROTOCOL 1 (normal protocol for identifying CVR to hypercapnia condition) 
First, all subjects underwent Protocol 1 (Fig. 1), and rested in an upright position in a 
comfortable chair following instrumentation. Five minutes of baseline data were 
recorded whilst the subjects breathed room air, wearing a face mask. The mean MCA V 
(MCA Vm) response to hypercapnia was induced by the step change in the fraction of 
inspired CO2 (FICO2, 0.00, 0.02, 0.035). In order to permit CO2 at the central respiratory 
chemoreceptors to reach a new steady-state, each FICO2 trial ran for 8 min which is 
sufficient in previous trials (Honda et al., 1983). 
PROTOCOL 2 (main study) 
Similarly, in Protocol 2, the MCA Vm response to hypercapnia was induced by the step 
change in FICO2 (0.00, 0.02, 0.035). Each FICO2 trial ran for 12 min. During each CO2 
condition, the change in ventilation (hyper- and hypo-ventilation) was used to 
manipulate PETCO2. To avoid the possible effects of different breathing patterns on the 
VE-PETCO2 relationship, in the hyperventilation trials, both VT and breathing frequency 
were altered deliberately by matching the breathing pattern to that recorded during 
hypercapnia trials. In the hypoventilation trial, VE was set to 80% of the steady-state 
value during the 0.00 FICO2 trial (i.e. during spontaneous breathing). The breathing 
pattern was estimated from the relationship between VE and VT in each subject. 
During hypo- and hyper-ventilation trials, the inspired and expired volume 
curves were continuously displayed on a screen monitor. Visual and audio signals were 
constructed from the breathing pattern of the subjects during the hypercapnia trials. The 
target VT level was simultaneously displayed on the same screen monitor in each trial. 
The subjects were instructed to match their volume curve with the target VT level, and to 
breathe according to the sound of the metronome. As a result, both the VT and breathing 
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frequency, and thus VE, were precisely controlled with visual and audio feedback 
specifically for each individual. 
Data processing 
Signals from the mass spectrometer, flow sensor, pressure transducer, cardio-tachometer 
and transcranial Doppler ultrasonography were synchronized on-line using a personal 
computer, and displayed continuously during all experiments. The signals were logged at 
200 Hz using a 12-bit analog-to-digital converter (AD12-8(PM) CONTEC Co., Ltd, Osaka, 
Japan). The analytical software program is custom-made by our laboratory. 
Measurements variables, HR, VE, VT, PETO2, PETCO2 and MCA Vm, were averaged over 
30s at the end of each stage in Protocol 1 and 2. Mean blood pressure (MBP) was 
averaged from two time points within each stage.  
Statistical Analysis 
Data were analyzed using the Statistics Package for Social Scientists (IBM SPSS 
Statistics Version 22.0). Differences between values were evaluated using a two-way 
repeated-measures analysis of variance (ANOVA, gas concentration<0, 2.0 and 3.5%> × 
respiration<hypo-, normo-, hyper-ventilation>) followed by a Student‐Newman‐Keuls 
post-hoc tests. Pearson’s correlation coefficient evaluated the relationship between 
relative changes in VE and PETCO2. A P < 0.05 denoted statistical significance for all 
two-tailed tests. 
Results 
In the present study, subjects voluntarily changed ventilation to manipulate PETCO2 
under stepwise inhalation of CO2 gas concentrations (0, 2.0 and 3.5%). In order to 
manipulate ventilation, each subject changed respiratory rate and VT, according to his or 
her individual breathing pattern obtained with regular breathing. Expectedly, all 
subjects were able to change their VE to the modified target during each condition e.g. 
hypercapnia (Table 1 and Fig. 2). Subsequently, PETCO2 was manipulated by the change 
in inhaled CO2 gas concentration and/or VE (Fig. 3). 
The change in PETCO2 during hyper-, normo-, hypo-ventilation did not effect HR 
(P=0.511, Table 1) but did change MAP (P=0.041, Table 1). Regarding the response of 
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MCA Vm to the change in PETCO2, the normo-ventilation CVR in protocol 2 was similar 
with the CVR in protocol 1 (Fig 4A). However, from baseline (norm-ventilation condition), 
the CVR response (the relationship between PETCO2 and MCA Vm) was reset upwards 
and downwards by hypoventilation and hyperventilation, respectively (Fig 4B) without 
any change in the slope of the linear relationship between PETCO2 and MCA Vm 
(P=0.301, Fig. 4C). 
Discussion 
One novel finding of the present study was that CVR, determined using the traditional 
method, was modified by voluntary changes in respiration during hypercapnia. The 
findings of the present study provide the possibility that an alteration in the respiratory 
system may underestimate or overestimate CVR determined by traditional methods in 
healthy adults.  
The concept of the traditional method for determining CVR is that arterial CO2 
concentration, e.g. PETCO2, PaCO2, is an independent variable that determine changes in 
CBF. At least, it is thought that CO2 is a much stronger mediator of CBF compared with 
other physiological factors. For example, arterial blood pressure has a limit to contribute 
to changes in CBF because of cerebral autoregulation (Lassen, 1959). Therefore, it was 
expected that using the traditional CVR method, even ventilation-induced change in CO2 
as well as inspiratory CO2 gas can identify characteristics of CBF regulation on one 
linear response CVR curve. For example, the operating point of CVR should be moving 
along its response curve by a respiratory-mediated alteration in CO2 (grey arrows, Fig. 
5A). Our data of the present study clearly demonstrated that the response of CBF to 
hyper- or hypo-ventilation induced-change in PETCO2 was likely similar to the 
relationship between inspiratory CO2 gas-induced change in PETCO2 and CBF under the 
hypercapnia condition (Slope, P=0.301, Fig 4B and C). However, in contrast to this 
traditional concept, the operating point of CVR did not follow the typical response curve 
during hypo- or hyper-ventilation (black arrow, Fig. 5A). In other words, the CVR 
response curve shifted upwards or downwards by hypo-or hyper-ventilation, respectively. 
These findings mean that hypercapnia evokes hyperventilation via the central 
respiratory chemoreflex, and consequently it moves the operating point of CVR 
downwards outside of its typical response curve. In contrast, this response 
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(hyperventilation) does not occur during normocapnia because there is no central 
respiratory chemoreflex (no change in ventilation) (Fig 5B). Taken together, the 
traditional method for determining CVR does not maintain resting ventilation in healthy 
subjects because of the 5-6% stimulation of hypercapnia. Therefore, our findings suggest 
that the respiratory response to CO2 may modify the CVR determined by the traditional 
method, that may under- or overestimate actual cerebrovascular responses to CO2. Also, 
an increase in MAP was observed during the normocapnia hypoventilation condition 
(Table 1). The change in perfusion pressure may also modify the CVR response, and 
hence the change in perfusion pressure may be another limitation for the traditional 
methods to determine CVR. In the present study, the effect of changes in MAP on CBF 
could not be identified, thus, it is unclear whether CBF is independent from changes in 
perfusion pressure using this method. Further investigations are needed to identify the 
effect of changes in perfusion pressure on CVR. An important point of the present study 
is that, regardless of change in MAP, the operating point of CVR did not follow the 
typical response curve during hypo- and hyperventilation. However, the physiological 
mechanism responsible for the changes in ventilation-induced shift of the CVR response 
curve is unknown from the data in the present study. 
Previous studies suggest that the respiratory system partly plays a role in CBF 
regulation (Ogoh et al., 2008; Ogoh et al., 2009). Importantly, both of these systems are 
sensitive to the same mediator, i.e., CO2, at a set point. Therefore, it is physiologically 
plausible that these systems are closely linked (Ogoh, 2019). The CBF response to 
hypercapnia was inversely related to the increase in ventilation, indicating that a lower 
CVR may result in less CO2 washout and consequently causes greater ventilatory 
stimulation via a central respiratory chemoreflex (Peebles et al., 2007). Also, some 
previous studies (Xie et al., 2006; Cummings et al., 2007) reported that changes in CVR 
affect stability of the ventilatory responsiveness to CO2 via alterations in the degree of 
washout in central chemoreceptor hydrogen [H+]. Clinically, respiratory disease such as 
sleep apnea or chronic hypoxia modifies CBF regulation (Ogoh et al., 2013; Ogoh et al., 
2014; Ponsaing et al., 2018). Moreover, patients with congenital central hypoventilation 
syndrome (CCHS) lack chemoreceptor control of breathing and seriously hypoventilate 
during non-rapid eye movement (non-REM) sleep. Many CCHS subjects breathe 
adequately during many waking behaviors associated with arousal, cognitive activity or 
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exercise (Shea, 1997). However, in these patients CBF regulation is impaired, and 
subsequently results in abnormal cerebral blood oxygenation and volume changes to CO2 
and O2 challenges (Macey et al., 2003; Macey et al., 2010). The CCHS patients showed 
28% higher overall CBF, and this may relate to high CO2 levels (Macey et al., 2010). 
Taken together, it is reasonable to physiologically suggest that the change in ventilation 
via central respiratory chemoreflex modifies the response of CBF in order to maintain an 
adequate arterial CO2 concentration for brain homeostasis.  
One important aspect regarding our results is that traditional CVR using 
hyperventilation-induced hypocapnia includes the influence of central drive (respiratory 
drive), which modifies the CBF response to changes in arterial CO2 concentration. On the 
other hand, hypercapnia stimulation with the traditional CVR method does not include 
higher central drive (respiratory drive) because hypercapnia is caused by an increase in 
respiratory CO2 gas concentration. However, the high hypercapnia condition activates 
central chemoreceptors and subsequently causes hyperventilation as well as 
hypertension (Table 1). In contrast, a mild hypercapnia (FiCO2 2.00) did not cause 
hyperventilation, indicating that the mild hypercapnia condition did not activate the 
central chemoreflex. Using the traditional method for determining CVR, therefore, 
arterial CO2 concentration may not be an independent variable to determine CBF. This is 
because hypo-, normo- and hyper-capnia conditions includes different physiological 
factors (higher central drive, central chemoreflex or arterial blood pressure) that may 
exert separate influences on the cerebral vasculature. These findings also suggest that it 
may be necessary to distinguish between the CBF response determined by hypocapnia 
and hypercapnia as a part of complete CVR profile.  
Moreover, we may need to carefully consider the limitations of the traditional 
method and evaluation for determining CVR, to avoid an under- or overestimation in the 
CVR characteristic. For example, it takes ~ 7 min to reach a steady-state of the response 
of VE to the change in arterial CO2 (Honda et al., 1983). However, most previous studies 
use only 3-4 min of CO2 stimulation to identify the CBF response for determining CVR, 
because the CBF response to CO2 manipulation is quick. If respiration modifies the CVR, 
this protocol (3-4 min) may be too short to identify a complete CVR profile because of the 
lack of time for an attainment of respiratory steady-state. To identify an exact CVR, the 
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response of CBF to change in CO2 may need to be evaluated during steady-state 
ventilation in order to reduce the influence of changes in respiration on CBF. 
Clinical Implications 
Our findings may also have clinical implications. For example, an attenuation in CVR in 
patients with respiratory disease (Hartmann et al., 2012; Lewis et al., 2019) may not be 
due to only alterations in the cerebral vasculature. CVR may be associated with the 
respiratory system directly as well as an impaired cerebral vasculature response to 
changes in arterial CO2. Therefore, it may be difficult to compare CVR determined by the 
traditional method simply between healthy subjects and patients with respiratory 
disease. 
Limitations 
In the methods determining CVR using PETCO2, it is based on the notion that PETCO2 is 
closely related to PaCO2. Although the PETCO2 estimate of PaCO2 may have limitations 
in this study, our previous studies revealed that PETCO2 was tightly correlated with 
PaCO2 throughout the hypercapnic and hypocapnic range under hypercapnia, and hyper- 
and hypo-ventilation conditions across various experimental conditions (Miyamoto et al., 
2014). Therefore, it seems that the change in PETCO2 observed during these experimental 
conditions likely reflect changes in PaCO2. On the other hand, Robbins et al. (Robbins et 
al., 1990) reported that PETCO2 was shown to consistently underestimate PaCO2, a 
finding that is consistent with our literature (Miyamoto et al., 2014; Miyamoto et al., 
2015). Jones et al. (Jones et al., 1979) reported that PETCO2 is higher than PaCO2 when 
FICO2 are increased, whereas it is lower under normal conditions. Therefore, the values 
of cerebral CO2 reactivity (CVR) may be underestimated using PETCO2 as opposed to 
PaCO2. Second, the visual feedback method made it possible to control accurately both 
the VT and breathing frequency, and thus VE. However, the inspiration and expiration 
duration during the CVR trials were not controlled. Therefore, this non-physiological 
respiration pattern might have also affected the PETCO2 response to VE. However, we 
have examined the CBF response to change in ventilation (hyper- or hypo-ventilation) 
under different inhaled CO2 gas concentrations. Thus, our interpretation of the observed 
differences in CBF in each experimental condition is likely to be valid. 
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Conclusion 
In the present study, we successfully manipulated VE during hypercapnia via control of 
respiratory rate and VT. Importantly, this was according to each individual’s respiratory 
pattern. Under hyper- or hypo-ventilation, the relationship between change in PETCO2 
via respiratory CO2 gas and CBF was unchanged from that during normal breathing. 
However, the response of CBF to hyper- or hypo-ventilation induced-change in PETCO2 
was different from that caused by only changes in inspiratory CO2 gas concentration. 
Thus, it is likely that the upwards and downwards shift in CVR by hypo- and 
hyperventilation, respectively. Since respiration modifies the CVR function curve, the 
stability of respiration may be important to determine CVR with the traditional methods. 
 
  
CVR and respiration 
Ogoh et al. 
This article is protected by copyright. All rights reserved. 
 
References 
Cummings KJ, Swart M & Ainslie PN. (2007). Morning attenuation in cerebrovascular CO2 
reactivity in healthy humans is associated with a lowered cerebral oxygenation and an 
augmented ventilatory response to CO2. J Appl Physiol (1985) 102, 1891-1898. 
 
Glodzik L, Randall C, Rusinek H & de Leon MJ. (2013). Cerebrovascular reactivity to carbon 
dioxide in Alzheimer's disease. J Alzheimers Dis 35, 427-440. 
 
Hartmann SE, Pialoux V, Leigh R & Poulin MJ. (2012). Decreased cerebrovascular response to 
CO2 in post-menopausal females with COPD: role of oxidative stress. Eur Respir J 40, 
1354-1361. 
 
Honda Y, Hayashi F, Yoshida A, Ohyabu Y, Nishibayashi Y & Kimura H. (1983). Overall "gain" of 
the respiratory control system in normoxic humans awake and asleep. J Appl Physiol 
Respir Environ Exerc Physiol 55, 1530-1535. 
 
Jones NL, Robertson DG & Kane JW. (1979). Difference between end-tidal and arterial PCO2 in 
exercise. J Appl Physiol Respir Environ Exerc Physiol 47, 954-960. 
 
Kety SS & Schmidt CF. (1946). The effects of active and passive hyperventilation on cerebral blood 
flow, cerebral oxygen consumption, cardiac output, and blood pressure of normal young 
men. J Clin Invest 25, 107-119. 
 
CVR and respiration 
Ogoh et al. 
This article is protected by copyright. All rights reserved. 
Kety SS & Schmidt CF. (1948a). The Effects of Altered Arterial Tensions of Carbon Dioxide and 
Oxygen on Cerebral Blood Flow and Cerebral Oxygen Consumption of Normal Young Men. 
J Clin Invest 27, 484-492. 
 
Kety SS & Schmidt CF. (1948b). The Nitrous Oxide Method for the Quantitative Determination of 
Cerebral Blood Flow in Man: Theory, Procedure and Normal Values. J Clin Invest 27, 
476-483. 
 
Lassen NA. (1959). Cerebral blood flow and oxygen consumption in man. Physiol Rev 39, 183-238. 
 
Lewis N, Gelinas JCM, Ainslie PN, Smirl JD, Agar G, Melzer B, Rolf JD & Eves ND. (2019). 
Cerebrovascular function in patients with chronic obstructive pulmonary disease: the 
impact of exercise training. Am J Physiol Heart Circ Physiol 316, H380-H391. 
 
Macey PM, Alger JR, Kumar R, Macey KE, Woo MA & Harper RM. (2003). Global BOLD MRI 
changes to ventilatory challenges in congenital central hypoventilation syndrome. Respir 
Physiol Neurobiol 139, 41-50. 
 
Macey PM, Kumar R, Ogren JA, Woo MA & Harper RM. (2010). Images in sleep medicine. Altered 
cerebral blood flow in a patient with congenital central hypoventilation syndrome. Sleep 
Med 11, 589-590. 
 
Markus H & Cullinane M. (2001). Severely impaired cerebrovascular reactivity predicts stroke 
and TIA risk in patients with carotid artery stenosis and occlusion. Brain 124, 457-467. 
 
CVR and respiration 
Ogoh et al. 
This article is protected by copyright. All rights reserved. 
Markwalder TM, Grolimund P, Seiler RW, Roth F & Aaslid R. (1984). Dependency of blood flow 
velocity in the middle cerebral artery on end-tidal carbon dioxide partial pressure--a 
transcranial ultrasound Doppler study. J Cereb Blood Flow Metab 4, 368-372. 
 
Miyamoto T, Bailey DM, Nakahara H, Ueda S, Inagaki M & Ogoh S. (2014). Manipulation of 
central blood volume and implications for respiratory control function. Am J Physiol Heart 
Circ Physiol 306, H1669-1678. 
 
Miyamoto T, Nakahara H, Ueda S, Manabe K, Kawai E, Inagaki M, Kawada T & Sugimachi M. 
(2015). Periodic Breathing in Heart Failure Explained by Dynamic and Static Properties of 
Respiratory Control. Clin Med Insights Cardiol 9, 133-142. 
 
Ogoh S. (2019). Interaction between the respiratory system and cerebral blood flow regulation. J 
Appl Physiol (1985). 
 
Ogoh S & Ainslie PN. (2009a). Cerebral blood flow during exercise: mechanisms of regulation. J 
Appl Physiol (1985) 107, 1370-1380. 
 
Ogoh S & Ainslie PN. (2009b). Regulatory mechanisms of cerebral blood flow during exercise: new 
concepts. Exerc Sport Sci Rev 37, 123-129. 
 
Ogoh S, Ainslie PN & Miyamoto T. (2009). Onset responses of ventilation and cerebral blood flow 
to hypercapnia in humans: rest and exercise. J Appl Physiol (1985) 106, 880-886. 
 
CVR and respiration 
Ogoh et al. 
This article is protected by copyright. All rights reserved. 
Ogoh S, Hayashi N, Inagaki M, Ainslie PN & Miyamoto T. (2008). Interaction between the 
ventilatory and cerebrovascular responses to hypo- and hypercapnia at rest and during 
exercise. J Physiol 586, 4327-4338. 
 
Ogoh S, Nakahara H, Ueda S, Okazaki K, Shibasaki M, Subudhi AW & Miyamoto T. (2014). 
Effects of acute hypoxia on cerebrovascular responses to carbon dioxide. Exp Physiol 99, 
849-858. 
 
Ogoh S, Sato K, Nakahara H, Okazaki K, Subudhi AW & Miyamoto T. (2013). Effect of acute 
hypoxia on blood flow in vertebral and internal carotid arteries. Exp Physiol 98, 692-698. 
 
Peebles K, Celi L, McGrattan K, Murrell C, Thomas K & Ainslie PN. (2007). Human 
cerebrovascular and ventilatory CO2 reactivity to end-tidal, arterial and internal jugular 
vein PCO2. J Physiol 584, 347-357. 
 
Ponsaing LB, Lindberg U, Rostrup E, Iversen HK, Larsson HBW & Jennum P. (2018). Impaired 
cerebrovascular reactivity in obstructive sleep apnea: a case-control study. Sleep Med 43, 
7-13. 
 
Richiardi J, Monsch AU, Haas T, Barkhof F, Van de Ville D, Radu EW, Kressig RW & Haller S. 
(2015). Altered cerebrovascular reactivity velocity in mild cognitive impairment and 
Alzheimer's disease. Neurobiol Aging 36, 33-41. 
 
Robbins PA, Conway J, Cunningham DA, Khamnei S & Paterson DJ. (1990). A comparison of 
indirect methods for continuous estimation of arterial PCO2 in men. J Appl Physiol (1985) 
68, 1727-1731. 
CVR and respiration 
Ogoh et al. 
This article is protected by copyright. All rights reserved. 
 
Shea SA. (1997). Life without ventilatory chemosensitivity. Respir Physiol 110, 199-210. 
 
Xie A, Skatrud JB, Morgan B, Chenuel B, Khayat R, Reichmuth K, Lin J & Dempsey JA. (2006). 
Influence of cerebrovascular function on the hypercapnic ventilatory response in healthy 




Conflict of interest 
No conflicts of interest, financial or otherwise, are declared by the authors. 
Author contributions 
Author contributions: S.O., T.M. conception and design of research; S.O., K.S., T.W., 
K.T., S.S., G.I. performed experiments; S.O., K.S., T.M. analyzed data; S.O., K.S., T.M. 
interpreted results of experiments; S.O. prepared figures; S.O., T.B., S.S., T.M. drafted 
manuscript; all authors edited and revised manuscript; all authors approved final 
version of manuscript. 
Funding 
This study was supported, in part, by a Grant-in-Aid for Scientific Research [grant 
number 15H003098] from the Japanese Ministry of Education, Culture, Sports, Science 
and Technology. 
Acknowledgements 
We appreciate the commitment of all participants of this study. 
  
CVR and respiration 
Ogoh et al. 
This article is protected by copyright. All rights reserved. 
Table 1. Respiratory and hemodynamic response to change in the fraction of inspired CO2 
(FICO2) and respiration. 
 
FiCO2 

















 Hypo 65 ± 14 10.4±3.9*#$ 13.2±4.5 862±353 39±5 103±11 100±5# 66±15 
0 Norm 57 ± 14 15.6±8.1* 16.0±6.5 1012±298 37±6 110±10 96±7 62±10 
 Hyper 47 ± 10 16.9±6.5* 15.7±5.1 1180±586 34±5 115±8 92±12* 71±13 
 Hypo 63 ± 15 13.0±4.5#$ 14.3±6.0 961±264 42±5 124±7 97±7 61±13 
0.02 Norm 56 ± 15 15.8±4.2*# 15.8±5.1 1086±285 40±4 131±7 99±9 64±8 
 Hyper 51± 18 19.5±4.3* 16.8±4.7 1222±343 38±3 136±4 94±7* 68±13 
 Hypo 69 ± 20 15.2±3.8#$ 16.4±6.0 988±246 46±2 124±9 99±7 73±35 
0.035 Norm 63 ± 17 22.3±2.9# 17.6±4.8 1366±408 44±3 132±8 97±6 66±10 
 Hyper 54 ± 14 26.8±4.4 18.9±5.5 1533±511 42±3 136±7 102±7 69±11 
 Respiration P<0.001 P<0.001 P=0.002 P<0.001 P<0.001 P<0.001 P=0.284 P=0.455 
P-Value CO2 P=0.133 P<0.001 P=0.002 P=0.002 P<0.001 P<0.001 P=0.291 P=0.418 
 Interaction P=0.840 P=0.025 P=0.804 P=0.125 P=0.854 P=0.966 P=0.041 P=0.566 
Values are means ± SD. hypo, hypoventilation; norm, normoventilation; hyper, 
hyperventilation; MCA Vm, middle cerebral artery mean blood velocity; VE, ventilation; 
RR, respiratory rate; VT, tidal volume; PETCO2, end-tidal partial pressure of carbon 
dioxide; PETO2; end-tidal partial pressure of oxygen, MAP, mean arterial pressure; HR, 
heart rate. *Different from 3.5%, P<0.05 # Different from hyperventilation, P<0.05, $ 
Different from normoventilation, P<0.05. 
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Figure Legends 
Figure 1. Experimental protocol 1 and protocol 2. 
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Figure 2. Change in ventilation by hypo- (Hypo), normo- (Norm), hyper-ventilation 
(Hyper) under hypercapnia condition (0, 2, 3.5% CO2). Values are means ± SE. 
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Figure 3. Change in end-tidal partial pressure of carbon dioxide (PETCO2) by ventilation 
(hypo-, normo-, hyper-ventilation; Hypo, Norm, Hyper) and inspiratory CO2 gas 
concentration (0, 2, 3.5%). Values are means ± SE. 
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Figure 4. A, The response of middle cerebral artery mean blood velocity (MCA Vm) to 
change in end-tidal partial pressure of carbon dioxide (PETCO2) during norm-ventilation 
(free-breathing) in protocol 1 and 2; B, The response of MCA Vm to change in PETCO2 
during hypo- (Hypo), normo- (Norm) and hyper-ventilation (Hyper) in Protocol 2; C, the 
slope of the liner relationship between PETCO2 and MCA Vm during Hypo, Norm and 
Hyper. Values are means ± SE. 
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Figure 5. A, In the concept of CVR, the operating point of CVR should move along the 
response curve via respiratory alteration-induced changes in CO2 (grey arrow). In the 
present study, the operating point shifted from its normal response curve during hypo- or 
hyperventilation (black arrow); B, In the traditional method of determining CVR, high 
CO2 stimulates the central respiratory chemoreflex, and subsequently causes 
hyperventilation. Thus, the hypercapnia condition shifts the operating point of CVR 
downwards, outside of the normal (typical) response curve observed during normocapnia 
(baseline).  
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